USE OF INTRAVENOUS STILBESTROL DIPHOSPHATE IN PATIENTS WITH PROSTATIC CARCINOMA REFRACTORY TO CONVENTIONAL HORMONAL MANIPULATION

The patient presenting with severe bone pain after primary hormonal therapy, with vertebral collapse, or with uremia resulting from ureteric obstruction should be considered for intravenous stilbestrol diphosphate therapy